• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Connecticut approves $291 million funding for Jackson Laboratory

Connecticut approves $291 million funding for Jackson Laboratory

November 2, 2011
CenterWatch Staff
The Connecticut legislature has approved $291 million in bond funding to build a new Jackson Laboratory center for personalized medicine and systems genomics in the state.
 
The research center, to be known as The Jackson Laboratory for Genomic Medicine, will be the next phase of Gov. Dannel Malloy's bioscience Connecticut initiative to build the biomedical industry in Connecticut. JAX Genomic Medicine will focus on complex genetics of human disease through the intensive use of computational strategies and animal model systems.
 
Plans call for JAX Genomic Medicine to be housed in a 173,500-square-foot building to be erected on 17 acres of land provided by the state, located near the campus of the University of Connecticut Health Center in Farmington.
 
The research center is projected to employ 320 people within the first 10 years, and 660 within 15 to 20 years. Thirty senior scientists, or principal investigators, will each head a laboratory research group, supported by scientific services and administrative departments. The center will also dedicate space and staff for translating newly developed research applications into commercial products and services for personalized medicine, such as complex diagnostics or drug development.
 
The state of Connecticut will provide a total of $291 million in support to JAX Genomic Medicine over 10 years for construction, equipment and research collaborations. The total 20-year capital and research budget for the institute is estimated to be $1.1 billion, with Jackson providing $809 million through federal research grants, philanthropy and service income.
 
With state bond funding approved, Jackson executives will now develop the details of the project with state officials. Once a contractual agreement is in place, Jackson will begin the design of the JAX Genomic Medicine building and start recruiting scientists to work in interim facilities that will be provided by the UConn Health Center. Construction will begin by early 2013, and the facility is projected to be completed by late 2014.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing